Unknown

Dataset Information

0

Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations.


ABSTRACT: PURPOSE:Smooth muscle dysfunction syndrome (SMDS) due to heterozygous ACTA2 arginine 179 alterations is characterized by patent ductus arteriosus, vasculopathy (aneurysm and occlusive lesions), pulmonary arterial hypertension, and other complications in smooth muscle-dependent organs. We sought to define the clinical history of SMDS to develop recommendations for evaluation and management. METHODS:Medical records of 33 patients with SMDS (median age 12 years) were abstracted and analyzed. RESULTS:All patients had congenital mydriasis and related pupillary abnormalities at birth and presented in infancy with a patent ductus arteriosus or aortopulmonary window. Patients had cerebrovascular disease characterized by small vessel disease (hyperintense periventricular white matter lesions; 95%), intracranial artery stenosis (77%), ischemic strokes (27%), and seizures (18%). Twelve (36%) patients had thoracic aortic aneurysm repair or dissection at median age of 14 years and aortic disease was fully penetrant by the age of 25 years. Three (9%) patients had axillary artery aneurysms complicated by thromboembolic episodes. Nine patients died between the ages of 0.5 and 32 years due to aortic, pulmonary, or stroke complications, or unknown causes. CONCLUSION:Based on these data, recommendations are provided for the surveillance and management of SMDS to help prevent early-onset life-threatening complications.

SUBMITTER: Regalado ES 

PROVIDER: S-EPMC6034999 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations.

Regalado Ellen S ES   Mellor-Crummey Lauren L   De Backer Julie J   Braverman Alan C AC   Ades Lesley L   Benedict Susan S   Bradley Timothy J TJ   Brickner M Elizabeth ME   Chatfield Kathryn C KC   Child Anne A   Feist Cori C   Holmes Kathryn W KW   Iannucci Glen G   Lorenz Birgit B   Mark Paul P   Morisaki Takayuki T   Morisaki Hiroko H   Morris Shaine A SA   Mitchell Anna L AL   Ostergaard John R JR   Richer Julie J   Sallee Denver D   Shalhub Sherene S   Tekin Mustafa M   Estrera Anthony A   Musolino Patricia P   Yetman Anji A   Pyeritz Reed R   Milewicz Dianna M DM  

Genetics in medicine : official journal of the American College of Medical Genetics 20180104 10


<h4>Purpose</h4>Smooth muscle dysfunction syndrome (SMDS) due to heterozygous ACTA2 arginine 179 alterations is characterized by patent ductus arteriosus, vasculopathy (aneurysm and occlusive lesions), pulmonary arterial hypertension, and other complications in smooth muscle-dependent organs. We sought to define the clinical history of SMDS to develop recommendations for evaluation and management.<h4>Methods</h4>Medical records of 33 patients with SMDS (median age 12 years) were abstracted and a  ...[more]

Similar Datasets

| S-EPMC9283281 | biostudies-literature
| S-EPMC3573757 | biostudies-literature
| S-EPMC7038593 | biostudies-literature
| S-EPMC4762557 | biostudies-literature
| S-EPMC3812165 | biostudies-literature
| S-EPMC3940907 | biostudies-literature
| S-EPMC5651592 | biostudies-literature
| S-EPMC2680995 | biostudies-literature
| S-EPMC10416378 | biostudies-literature
| S-EPMC3828800 | biostudies-literature